← Browse by Condition
Medical Condition
stage iii prostate cancer ajcc v8
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 3
NCT05487846
Recruiting
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Enrollment
120 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT04725903
Recruiting
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
Enrollment
30 pts
Location
United States
Sponsor
Emory University
NCT04947254 Phase 2
Recruiting
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
Enrollment
200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05869682 Phase 2
Recruiting
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
Enrollment
210 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT05722288 Phase 2
Recruiting
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
Enrollment
60 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06650579 Phase 3
Recruiting
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Enrollment
72 pts
Location
United States
Sponsor
Emory University